Duality Biotherapeutics Inc/ADR DYBTY

The SEC does not publish structured financial data (XBRL) for Duality Biotherapeutics Inc/ADR, so there are no statement tables here. This is common for foreign companies that trade over the counter and for filers that only submit documents. Its filings are still listed below and on SEC EDGAR.

Recent SEC filings

Recent SEC filings
Form Description Filed Period
F-6EF Filing Sep 9, 2025 —

Company profile

Listed as
DYBTY (OTC), DUTBF (OTC)
Fiscal year ends
December 31
Incorporated in
Cayman Islands
Headquarters
Shanghai
SEC CIK
2085208

Source: SEC EDGAR filings. This is company-reported data, not investment advice.